Company Financials

ADMA Biologics, Inc. Financials

United States dollar

business ADMA Biologics, Inc. Company Profile

Main Stock Listing

NASDAQ: ADMA

Market Capitalization $4.27 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 20.79
Forward PE 19.02
Price to Sales TTM $8.73
Price to Book MRQ $9.88
Enterprise to Revenue 8.76
Enterprise to EBITDA 24.44

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 42.87%
Operating Margin 38.01%
Return on Assets TTM 21.76%
Return on Equity TTM 63.17%

Income Statement

Revenue TTM $488,559,008
Revenue per Share TTM $2.05
Quarterly Revenue Growth 12.00%
Gross Profit TTM $267,282,000
EBITDA $175,468,000
Net Income to Common TTM $209,447,008
Diluted EPS TTM $0.86
Quarterly Earnings Growth YoY 1.40%

Balance Sheet

Total Cash MRQ $61,385,000
Total Cash per Share MRQ $0.26
Total Debt MRQ $
Total Debt to Equity MRQ 19.28
Current Ratio MRQ 7.13
Book Value per Share MRQ $1.81

Cash Flow

Operating Cash Flow TTM $64,973,000
Levered Free Cash Flow TTM $2,958,500

ADMA Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 238,332,393
Float Shares 233,252,090
Avg 10 Volume 1,757,694
Avg 30 Volume None
Shares Short 18,829,424
Short Ratio 6.52
Short % of Shares 9.72%
% Held by Insiders 2.57%
% Held by Institutions 94.88%

Stock Price Summary

Beta 0.43
Fifty Two Week Low $13.50
Fifty Two Week High $25.67
Fifty Two Week Change -6.99%
Day 50 MA $17.48
Day 200 MA $18.20

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date